#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Asthma Dermatitis atopic Dementia Alzheimer's type Breast cancer metastatic Non-small cell lung cancer metastatic Type 2 diabetes mellitus More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Atopic keratoconjunctivitis Breast angiosarcoma Hypocalcaemia IPEX syndrome Primary myelofibrosis Extraskeletal ossification Colorectal adenocarcinoma Deafness bilateral Antisynthetase syndrome Soft tissue sarcoma Dementia with Lewy bodies Alveolar proteinosis Erdheim-Chester disease Cervix carcinoma recurrent Multiple system atrophy More trials…

    Learn about Rare Diseases

    Hereditary optic atrophy Osteosarcoma Proteus syndrome – Basic Information Mitochondrial myopathy – Trials in Disease Synovial sarcoma metastatic – Trials in Disease Andersen-Tawil syndrome Immunodeficiency congenital – Life with Disease Hepatoblastoma – Basic Information Alexander disease – Basic Information Rhabdomyosarcoma – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    [18F] CANAGLIFLOZIN PRILOCAINE HYDROCHLORIDE Triheptanoin Retinol Palmitate Ep0042 Dexchlorpheniramine Maleate Azd8205 Lisocabtagene Maraleucel Formoterol Fumarate Dihydrate Pemetrexed Diacid Monohydrate Brimonidine Betamethasone Dipropionate Dexamethasone Isonicotinate Sugammadex Dactylis Glomerata RO7284755 Ammonium Chloride Bp Ondansetron Hydrochloride Onasemnogene Abeparvovec Thalidomide More therapies…

    Learn about Your Condition

    Peritoneal abscess Tympanic membrane perforation Dystonia Mixed-type liposarcoma Infantile spasms Hypochondroplasia Laryngeal cancer stage I Gallbladder cancer Allergic respiratory disease Anal abscess Rectal cancer Osteosarcoma metastatic Large cell lung cancer stage 0 Renal cell carcinoma Polycystic ovarian syndrome More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Dermatitis atopic

  • Study on the Effectiveness and Safety of Methotrexate Compared to Placebo for Adults with Moderate to Severe Atopic Dermatitis

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Dermatitis atopic
    Investigated Drugs:
    • Desoximetasone
    • Folic Acid
    • Methotrexate
    Czechia France Italy Poland

  • Study on the Effect of a New Moisturiser with Glycerol and Urea on Skin Barrier in Adults with Atopic Dermatitis

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Dermatitis atopic
    Investigated Drugs:
    • Sodium Laurilsulfate
    • Glycerol
    • Urea
    Germany

  • Study on SAR444656 for Adults with Moderate to Severe Atopic Dermatitis

    Not recruiting

    2 1
    Investigated Diseases:
    • Dermatitis atopic
    Investigated Drugs:
    • Sar444656
    Czechia Germany Greece Poland

  • Study on Long-Term Safety and Efficacy of Amlitelimab for Patients with Moderate to Severe Atopic Dermatitis from Previous Trials

    Not recruiting

    4 1 1 1
    Investigated Drugs:
    • Amlitelimab
    Bulgaria Czechia Denmark France Germany Greece +7

  • Study on Optimizing Ciclosporin Treatment for Moderate to Severe Atopic Dermatitis in Adults, Adolescents, and Children

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Dermatitis atopic
    Investigated Drugs:
    • Ciclosporin
    Spain

  • Study on the Effect of a New Moisturiser with Paraffin and Liquid Paraffin on Preventing Eczema Relapse in Children

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Eczema
    • Dermatitis atopic
    Investigated Drugs:
    • Liquid Paraffin
    • Methylprednisolone Aceponate
    • Unsaturated Fatty Acids (C18 : 2)
    Germany Sweden
Previous Page
1 … 11 12 13 14 15
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!